Avalon GloboCare (NASDAQ: ALBT) faces Nasdaq $1 bid-price deficiency and cure deadline

Rhea-AI Filing Summary

Avalon GloboCare Corp. received a notice from Nasdaq that its common stock no longer meets the Nasdaq Capital Market minimum bid price requirement of $1.00 per share, after trading below that level for 30 consecutive business days through April 14, 2026.

The stock remains listed under the symbol ALBT, but the company has 180 days, until October 12, 2026, to regain compliance by achieving a closing bid of at least $1.00 for 10 consecutive business days. If it still does not comply, Avalon may qualify for an additional 180‑day period if it meets other Nasdaq listing standards and may consider actions such as a reverse stock split to cure the deficiency.

Positive

• None.

Negative

• Nasdaq bid-price deficiency and delisting risk: Avalon GloboCare’s stock has traded below Nasdaq’s $1.00 minimum for 30 consecutive business days, starting a 180‑day cure period and potentially an additional 180 days, after which Nasdaq may move to delist if compliance is not regained.

Insights

Equity market structure analyst

Nasdaq bid-price noncompliance puts Avalon’s listing status at clear risk.

Avalon GloboCare has fallen below Nasdaq’s $1.00 minimum bid price for 30 consecutive business days, triggering a formal deficiency notice. The stock remains on the Nasdaq Capital Market, but this begins a defined remediation timetable that can ultimately lead to delisting.

The company has until October 12, 2026 to record at least 10 straight trading days with a closing bid at or above $1.00. Failing that, it may get another 180 days if it satisfies other Nasdaq listing standards, and it explicitly notes potential use of a reverse stock split as a tool.

If Avalon cannot regain compliance even after a second period, Nasdaq may move to delist, though Avalon would then have the right to appeal before a Hearings Panel. Investors would need subsequent company disclosures to understand whether and when actions like a reverse split are pursued.

8-K Event Classification

Item 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

1 item

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Securities

The company received a delisting notice or transferred its listing to a different exchange.

Key Figures

Nasdaq minimum bid price: $1.00 per share Deficiency measurement period: 30 consecutive business days Initial cure period: 180 calendar days +2 more

5 metrics

Nasdaq minimum bid price $1.00 per share Required under Nasdaq Listing Rule 5550(a)(2)

Deficiency measurement period 30 consecutive business days Closing bids below $1.00 from March 1, 2026 to April 14, 2026

Initial cure period 180 calendar days Until October 12, 2026 to regain bid-price compliance

Required compliant trading stretch 10 consecutive business days Closing bid must be at least $1.00 per share

Potential additional cure period 180 days Possible second period if other listing standards are met

Key Terms

Nasdaq Listing Rule 5550(a)(2), Nasdaq Listing Rule 5810(c)(3)(A), Nasdaq Capital Market, minimum bid price requirement, +2 more

6 terms

Nasdaq Listing Rule 5550(a)(2) regulatory

"it is not in compliance with the minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2)"

Nasdaq Listing Rule 5810(c)(3)(A) regulatory

"Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists"

Nasdaq Capital Market financial

"for continued listing on The Nasdaq Capital Market"

The Nasdaq Capital Market is a platform where smaller, emerging companies can list their shares for trading by investors. It provides these companies with access to funding and visibility, helping them grow, much like a local marketplace where new vendors can introduce their products to potential customers. For investors, it offers opportunities to discover early-stage companies with growth potential.

minimum bid price requirement financial

"it is not in compliance with the minimum bid price requirements"

A minimum bid price requirement is a rule that a stock must trade above a set price for a specified period to stay listed on an exchange. It matters to investors because falling below that threshold can trigger warnings or removal from the exchange, which can cut liquidity, reduce visibility, and often lead to sharper declines in share value—think of it like a venue’s minimum dress code that, if not met, can bar a performer from the stage.

reverse stock split financial

"by effecting a reverse stock split, if necessary"

A reverse stock split is when a company reduces the number of its shares outstanding, making each share more valuable. For example, if you own 100 shares worth $1 each, a 1-for-10 reverse split would turn your 100 shares into 10 shares worth $10 each. Companies often do this to boost their stock price and appear more stable to investors.

delist regulatory

"Nasdaq will notify the Company of its determination to delist the Company’s common stock"

Delist means a company’s shares are removed from a public stock exchange so they can no longer be bought or sold on that market. Think of it like a product being taken off a supermarket shelf: the stock becomes harder to find, often leads to less trading, wider price swings, and reduced transparency, which matters to investors because it can limit ability to sell, change the value of holdings, and signal regulatory or financial problems.

Understanding 8-K Material Events →

false 0001630212 0001630212 2026-04-15 2026-04-15 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): April 15, 2026

AVALON GLOBOCARE CORP.

(Exact name of registrant as specified in its charter)

Delaware		001-38728		47-1685128
(State or other jurisdiction		(Commission File Number)		(IRS Employer
of incorporation)				Identification Number)

4400 Route 9 South, Suite 3100, Freehold, NJ 07728

(Address of principal executive offices, including zip code)

(732) 780-4400

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.0001 per share		ALBT		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

On April 15, 2026, Avalon GloboCare Corp. (the “Company”) was notified (the “Notification Letter”) by The Nasdaq Stock Market, LLC (“Nasdaq”) that it is not in compliance with the minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of $1.00 per share, and Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency continues for a period of 30 consecutive business days. Based on the closing bid price of the Company’s common stock between March 1, 2026 to April 14, 2026, the Company no longer meets the minimum bid price requirement. The Notification Letter has no immediate effect on the listing or trading of the Company’s common stock on The Nasdaq Capital Market and, at this time, the common stock will continue to trade on The Nasdaq Capital Market under the symbol “ALBT.”

The Notification Letter provides that the Company has 180 calendar days, or until October 12, 2026, to regain compliance with Nasdaq Listing Rule 5550(a)(2). To regain compliance, the bid price of the Company’s common stock must have a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days. If the Company does not regain compliance by October 12, 2026, an additional 180 days may be granted to regain compliance, so long as the Company meets The Nasdaq Capital Market continued listing requirement for market value of publicly-held shares and all other initial listing standards for The Nasdaq Capital Market, other than the minimum closing bid price requirement and notifies Nasdaq in writing of its intention to cure the deficiency during the second compliance period, by effecting a reverse stock split, if necessary. If the Company does not qualify for the second compliance period or fails to regain compliance during the second 180-day period, then Nasdaq will notify the Company of its determination to delist the Company’s common stock, at which point the Company will have an opportunity to appeal the delisting determination to a Hearings Panel.

The Company intends to monitor the closing bid price of its common stock and may, if appropriate, consider implementing available options, including, but not limited to, implementing a reverse stock split of its outstanding securities, to regain compliance with the minimum bid price requirement under the Nasdaq Listing Rules.

- 1 -

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	AVALON GLOBOCARE CORP.
Dated: April 17, 2026	By:	/s/ Luisa Ingargiola
	Name:	Luisa Ingargiola
	Title:	Chief Financial Officer

- 2 -

FAQ

Why did Avalon GloboCare (ALBT) receive a Nasdaq deficiency notice?

Avalon GloboCare received a Nasdaq deficiency notice because its common stock closed below the required $1.00 minimum bid price for 30 consecutive business days through April 14, 2026. This violates Nasdaq Listing Rule 5550(a)(2) for the Nasdaq Capital Market.

What does the Nasdaq minimum bid price rule require for ALBT stock?

Nasdaq Listing Rule 5550(a)(2) requires Avalon GloboCare’s common stock to maintain a minimum bid price of $1.00 per share. A deficiency is deemed to exist when the closing bid stays below this level for 30 consecutive business days.

How long does Avalon GloboCare have to regain Nasdaq compliance?

Avalon GloboCare has 180 calendar days, until October 12, 2026, to regain compliance. It must achieve a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days within this period.

Can Avalon GloboCare (ALBT) get more time to fix its Nasdaq listing issue?

If Avalon GloboCare does not regain compliance by October 12, 2026, Nasdaq may grant an additional 180‑day period. This is available if the company meets other initial Nasdaq Capital Market listing standards and states an intent to cure, possibly via a reverse stock split.

Will ALBT be immediately delisted from Nasdaq because of this notice?

No, ALBT will not be immediately delisted. The notice has no immediate effect on trading, and Avalon GloboCare’s common stock will continue to trade on the Nasdaq Capital Market under symbol ALBT while it attempts to regain compliance.

What actions might Avalon GloboCare take to regain Nasdaq bid price compliance?

Avalon GloboCare intends to monitor its stock’s closing bid price and may consider available options to regain compliance. The company specifically mentions potentially implementing a reverse stock split of its outstanding securities if appropriate under Nasdaq’s rules.

Filing Exhibits & Attachments

3 documents

Other Documents

• EX-101 XBRL SCHEMA FILE 3.0 KB
• EX-101 XBRL LABEL FILE 33.4 KB
• EX-101 XBRL PRESENTATION FILE 21.8 KB